You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,015.7% | -1,282.0% |
| ROCE | 2.6% |
| Latest | Forecast | |
|---|---|---|
| P/E | 179.8 | 0.0 |
| PEG | -1.8 | -999,999.0 |
| Price / Revenue | 87.9 | 82.5 |
| Price / Book value | 1.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 20.0% | 59.5% |
| PBT | -96.0% | n/a |
| EPS | -98.7% | 20.4% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | 2.54 | -70.71 | $0.11 | 18.4 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 20.75 | -68.44 | $-0.16 | -13.7 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 9.81 | 478.47 | $1.49 | 2.8 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 11.77 | 18.97 | $0.02 | 273.3 | -2.8 | -99% | n/a | 0.0% |
| Puretech Health receives $100m from sale of 55% stake in Karuna Therapeutics Sharecast News | 10 Nov |
|---|---|
| PureTech Health's Vor wins FDA fast-track approval for cancer drug Sharecast News | 10 Sep |
| Tuesday broker round-up Sharecast News | 24 Aug |
| PRTC’s Akili to Become Public & $162M Funding | 26-Jan-22 12:02 |
|---|---|
| PRTC's Gelesis to Debut on NYSE Today Ticker GLS | 14-Jan-22 07:00 |
| PureTech to Present at JPM Healthcare Conference | 07-Jan-22 12:00 |
| LYT-100 Shows Improved AE Profile vs Pirfenidone | 06-Jan-22 07:00 |
| Gelesis Adds to BOD & Declared Effective by SEC | 05-Jan-22 12:05 |